USP Formulary Guide Needs Overhaul To Meet Access Goal, PhRMA, BIO Say

The U.S. Pharmacopeia should completely overhaul its draft model formulary guidelines for Medicare Part D in order to fulfill its task of creating guidelines that prevent health plans from discriminating against certain Medicare beneficiaries, PhRMA and BIO said